doi:10.1016/j.virs.2022.11.007

[1]
Wei Yang, Songliu Yang, Lei Wang, Yuxin Zhou, Yu Xin, Hongxu Li, Wenjing Mu, Qi Wu, Lei Xu, Mingyan Zhao, Changsong Wang, Kaijiang Yu, 2022: Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China, Virologica Sinica, 37, 704-715. doi: 10.1016/j.virs.2022.07.014
[2]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
[3]
Peng Zhou, Zhenggang Han, Lin-Fa Wang, Zhengli Shi, 2013: Identification of Immunogenic Determinants of the Spike Protein of SARS-like Coronavirus, Virologica Sinica, 28, 92-96. doi: 10.1007/s12250-013-3292-y
[4]
Xingyu Wang, Kun Huang, Haini Jiang, Lijuan Hua, Weiwei Yu, Dan Ding, Ke Wang, Xiaopan Li, Zhong Zou, Meilin Jin, Shuyun Xu, 2020: Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility, Virologica Sinica, 35, 793-802. doi: 10.1007/s12250-020-00308-0
[5]
Ran Jia, Xiangshi Wang, Pengcheng Liu, Xiaozhen Liang, Yanling Ge, He Tian, Hailing Chang, Hao Zhou, Mei Zeng, Jin Xu, 2020: Mild Cytokine Elevation, Moderate CD4⁺ T Cell Response and Abundant Antibody Production in Children with COVID-19, Virologica Sinica, 35, 734-743. doi: 10.1007/s12250-020-00265-8
[6]
Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6
[7]
Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003
[8]
Xiao-Li Feng, Dandan Yu, Mi Zhang, Xiaohong Li, Qing-Cui Zou, Wentai Ma, Jian-Bao Han, Ling Xu, Cuixian Yang, Wang Qu, Zhong-Hua Deng, Junyi Long, Yanghaopeng Long, Mingkun Li, Yong-Gang Yao, Xing-Qi Dong, Jianxiong Zeng, Ming-Hua Li, 2022: Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates, Virologica Sinica, 37, 804-812. doi: 10.1016/j.virs.2022.09.007
[9]
Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029
[10]
Jianchun Wei, Hui Chen, Jing An, 2014: Recent progress in dengue vaccine development, Virologica Sinica, 29, 353-363. doi: 10.1007/s12250-014-3542-7
[11]
肖春惠, 杨占秋, 2001: The Development of The Hantan Virus Vaccine, Virologica Sinica, 16, 299-303.
[12]
Lianxing Liu, Chao Qiu, Yang Huang, Jianqing Xu, Yiming Shao, 2013: Potent T cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine, Virologica Sinica, 28, 109-115. doi: 10.1007/s12250-013-3303-z
[13]
Chunchen Wu, Wenzhong Yang, Xiaoxue Wu, Tianzhu Zhang, Yaoyao Zhao, Wei Ren, Jianbo Xia, 2020: Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women, Virologica Sinica, 35, 305-310. doi: 10.1007/s12250-020-00227-0
[14]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[15]
Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 901-912. doi: 10.1007/s12250-021-00378-8
[16]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006
[17]
Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, He Huang, Jianwei Wang, Zhendong Zhao, 2021: Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation, Virologica Sinica, 36, 890-900. doi: 10.1007/s12250-021-00369-9
[18]
Karen A O Martins, Travis K Warren, Sina Bavari, 2013: Characterization of a Putative Filovirus Vaccine: Virus-Like Particles, Virologica Sinica, 28, 65-70. doi: 10.1007/s12250-013-3306-9
[19]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[20]
Pingping Yao, Yachun Zhang, Yisheng Sun, Yulin Gu, Fang Xu, Bo Su, Chen Chen, Hangjing Lu, Dehui Wang, Zhangnv Yang, Biao Niu, Jiancai Chen, Lixia Xie, Lei Chen, Yajing Zhang, Hui Wang, Yuying Zhao, Yue Guo, Juncheng Ruan, Zhiyong Zhu, Zhenfang Fu, Dayong Tian, Qi An, Jianmin Jiang, Hanping Zhu, 2020: Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell, Virologica Sinica, 35, 348-350. doi: 10.1007/s12250-020-00241-2